Financhill
Buy
67

CSPCY Quote, Financials, Valuation and Earnings

Last price:
$4.45
Seasonality move :
13.1%
Day range:
$4.41 - $4.45
52-week range:
$2.15 - $5.83
Dividend yield:
2.79%
P/E ratio:
23.76x
P/S ratio:
3.53x
P/B ratio:
15.44x
Volume:
325
Avg. volume:
12.2K
1-year change:
80.99%
Market cap:
$12.6B
Revenue:
$4B
EPS (TTM):
$0.19

Earnings Data

Next earnings date for CSPCY
Apr 02
2026
Most recent earnings per share
$0.07
Beat by $0.07
(Mar 31/2025)
Consensus Estimate
--
(Mar 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSPCY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- $964.2M $0.07 -- --
09/30/2024 Q3 -- $894.1M $0.04 -- --
03/20/2024 Q4 -- $1.1B $0.06 -- --
09/30/2023 Q3 -- -- $0.07 -- --
09/15/2023 Q2 -- -- $0.07 -- --
03/31/2023 Q1 -- -- $0.07 -- --
12/31/2022 Q4 -- -- $0.08 -- --
09/30/2022 Q3 -- -- $0.07 -- --
06/30/2022 Q2 -- -- $0.08 -- --
03/31/2022 Q1 -- -- $0.07 -- --

CSPC Pharmaceutical Group Ltd. Earnings Questions

  • How Much did CSPC Pharmaceutical Group Ltd. Generate in Revenue Last Quarter?

    CSPC Pharmaceutical Group Ltd. reported $964.2M worth of top line sales in its most recent quarter.

  • Did CSPC Pharmaceutical Group Ltd. Beat Earnings Last Quarter?

    CSPC Pharmaceutical Group Ltd. announced earnings per share of $0.07 which represents a beat of analyst forecast a -- per share.

  • Is CSPC Pharmaceutical Group Ltd. Profitable?

    CSPC Pharmaceutical Group Ltd. reported $646.8M that represents $0.23 per share over the last quarter.

  • What is the Analyst Consensus for CSPC Pharmaceutical Group Ltd. EPS Next Year?

    CSPC Pharmaceutical Group Ltd.'s earnings are forecast to grow from $0.20 per share to -- per share next year representing an increase of --.

  • When is CSPC Pharmaceutical Group Ltd.'s Earnings Date?

    CSPC Pharmaceutical Group Ltd.'s next earnings date is April 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock